Moreover, the dAbPD−L1/CD24-mPDA@CuO2 NRs exhibit targeted chemodynamic therapy (CDT) with the ability to self-supply H2O2 within the tumor microenvironment, leading to efficient suppression of 4T1 breast tumors (Scheme 1B). The gene discussed is CD24; the disease is neoplasm.